US-based Praxis Precision has decided not to halt its Phase III trial examining its essential tremor (ET) therapy after an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results